You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug FLURANDRENOLIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for Flurandrenolide

Last updated: February 25, 2026

What is the current excipient strategy for Flurandrenolide?

Flurandrenolide, a potent topical corticosteroid used primarily for dermatitis and other inflammatory skin conditions, has implementations largely dictated by its formulation needs. Topical corticosteroids, including Flurandrenolide, require excipients that ensure stability, enhance absorption, and improve patient compliance.

Typical excipients used in Flurandrenolide formulations:

  • Adhesive Bases: Polyisobutylenes and polybutenes are common for patch formulations, ensuring adhesion to skin.
  • Carriers and Vehicles: Petrolatum, mineral oil, and alcohols such as ethanol aid in enhancing penetration and maintaining drug stability.
  • Penetration Enhancers: Propylene glycol and azone may be incorporated to increase skin permeability.
  • Preservatives and Stabilizers: Methylparaben, propylparaben, or tocopherols prevent microbial growth and oxidative degradation.
  • Emulsifiers: For cream formulations, parabens and cetyl alcohol stabilize emulsions.

Formulation strategies:

  • Creams and Ointments: Use hydrophilic or lipophilic bases depending on the desired drug release profile.
  • Transdermal Patches: Incorporate adhesives, permeation enhancers, and stabilizers; polyisobutylenes dominate as patch adhesives.
  • Gel Formulations: Contain carbomer or hydroxyethyl cellulose as gelling agents, with alcohols or glycols as solvents.

Regulatory considerations:

Excipient selection aligns with pharmacopeial standards (USP, EP). For sensitive skin, excipients with low allergenicity, such as oleyl alcohol or specific carbomers, are preferred.

What are the key commercial opportunities linked to excipient innovations?

Growth in topical corticosteroid markets

Global topical corticosteroid market estimated at USD 4.2 billion in 2022, with a compound annual growth rate (CAGR) around 4.5% (source [1]). Flurandrenolide's segment benefits from advancements in formulation technology, driving differentiation.

Opportunities in transdermal delivery systems

  • Enhanced bioavailability: Use of novel penetration enhancers or vesicular carriers (liposomes, ethosomes) can facilitate systemic absorption, expanding applications.
  • Patient compliance: Developing patches with improved adhesive properties and reduced skin irritation increases acceptance.

Sustainable excipients

Growing regulatory and consumer pressure favor the adoption of biodegradable and sustainably sourced excipients, like plant-derived emulsifiers or natural oils.

Proprietary excipient platforms

Collaborations with excipient manufacturers to develop unique delivery platforms—e.g., microemulsions or nanocarriers—offer opportunities for patenting and premium pricing.

Formulation for niche indications

Localized applications requiring minimal systemic absorption, such as facial dermatitis, demand excipients that limit penetration while maintaining efficacy, opening niche markets.

Differentiating through excipient patenting

Patented excipients or unique combinations can extend patent life, prevent generic competition, and command higher margins.

How do excipient strategies impact commercial success?

  • Efficacy and Safety: Proper excipient choice defines drug stability, alters pharmacokinetics, and influences side effect profile.
  • Regulatory Approval: Novel excipients requiring new safety data can delay approval but enable product differentiation.
  • Manufacturing Costs: Cost-efficient excipients with high compatibility reduce production expenses.
  • Market Differentiation: Innovative excipient combinations lead to differentiation, positioning products for premium segments.

Key trends influencing excipient strategies

  • Personalized medicine: Formulations tailored to specific patient groups, e.g., sensitive skin, require specialized excipients.
  • Combination products: Fixed-dose combinations with excipients that optimize multiple active ingredients.
  • Regulatory tightening: Increased scrutiny on excipient safety necessitates transparent safety data and may limit some traditional excipients.

Summary table

Aspect Details
Market Size USD 4.2 billion (2022)
CAGR 4.5% (2022-2027)
Key Formulation Types Creams, ointments, patches, gels
Common Excipients Petrolatum, PEGs, alcohols, adhesives
Innovation Focus Penetration enhancers, biodegradable excipients, patented platforms

Key Takeaways

  • Excipient strategies for Flurandrenolide hinge on delivery method, stability, and patient compliance.
  • Market growth and technological advances create opportunities in innovative formulations and delivery systems.
  • Sustainable and proprietary excipients represent long-term differentiation tools.
  • Regulatory trends prioritize safety and transparency, influencing excipient selection.
  • Niche applications and pairing with novel delivery platforms broaden commercial potential.

FAQs

  1. What excipients are critical for Flurandrenolide topical formulations?
    Excipients such as petrolatum, alcohols, penetration enhancers, preservatives, and adhesives are critical for stability, absorption, and adhesion.

  2. How can excipient innovation extend Flurandrenolide's patent life?
    Development of proprietary excipient combinations or delivery platforms can lead to patent filings, delaying generic competition.

  3. What regulatory factors influence excipient choice?
    Safety profiles, allergenicity, and compliance with pharmacopeial standards (USP, EP) guide excipient approval.

  4. Are natural or biodegradable excipients a significant trend?
    Yes. Increasing demand for sustainable products prompts the adoption of plant-based and biodegradable excipients.

  5. How does excipient selection affect market differentiation?
    Unique excipient platforms can improve efficacy, reduce side effects, and enable formulations targeting specific patient needs, supporting premium pricing.


References

[1] MarketsandMarkets. (2022). Topical Corticosteroids Market by Type, Application, and Region: Global Forecast to 2027.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.